Lastly, adiponectin levels were independently associated with restenosis, but both HOMA-IR (Homeostatic model assessment of insulin resistance) and adiponectin were independently associated with de novo ischemic heart disease and the incidence of new percutaneous coronary interventions in patients with normal glucose tolerance [201]. This evidence concerns the gene ADIPOQ and coronary artery disorder.